58 research outputs found
Einflüsse von Minimalbodenbearbeitung und Transfermulch auf den Initialbefall und die Populationsentwicklung des Kartoffelkäfers (Leptinotarsa decemlineata)
The growing economic importance of potatoes in organic agriculture has led to the intensification of potato production and farm specialization. This has in turn increased the occurrence of the Colorado potato beetle, the most important potato insect pest worldwide. The effects of the application of green manure mulch to potatoes, which
improves water and nutrient availability were investigated in a long-term field experiment, comparing two potato cultivation systems: conventional ploughing and hilling versus reduced tillage with dead mulch application. There were no differences in the initial degree of potato beetle infestation. However, a significant reduction in the
number of potato beetle larvae and eggs was observed. The mechanism behind the effects should examined in future experiments
Tn5 mutagenesis as a method for determination of necessary genetic features of bacterial antagonists
Reduzierte Bodenbearbeitung, Zwischenfrüchte und Transfermulch für einen bodenregenerierenden Anbau
Spezialisierung, Intensivierung und Ökonomisierung erschweren Bodenstrukturverbesserung und den Pflanzenschutz im ökologischen Landbau. Um die nachhaltigen Ziele des Ökolandbaus zu erreichen muss parallel eine ökologische Intensivierung stattfinden. Durch Zwischenfrüchte, reduzierter Bodenbearbeitung und Mulch aus Gründüngern soll der Bodenzustand während des Anbaus verbessert, Erosion vermieden und der Pflanzenschutzaufwand verringert werden, für einen resilienten Anbau. In dem Workshop werden Akteure aus Praxis, Beratung und Wissenschaft ihre Erkenntnisse zum bodenschonenden Anbau zusammenfassen. In Arbeitsgruppen werden Fragen der Umsetzung, Herausforderungen und einer Vernetzung erörtert. Die abschließende Diskussion bietet Raum um offene Fragen und Wiedersprüche zu debattieren
Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
Background Staphylococcus aureus is an important pathogen in cystic fibrosis
(CF). However, it is not clear which factors are associated with worse lung
function in patients with persistent S. aureus airway cultures. Our main
hypothesis was that patients with high S. aureus density in their respiratory
specimens would more likely experience worsening of their lung disease than
patients with low bacterial loads. Methods Therefore, we conducted an
observational prospective longitudinal multi-center study and assessed the
association between lung function and S. aureus bacterial density in
respiratory samples, co-infection with other CF-pathogens, nasal S. aureus
carriage, clinical status, antibiotic therapy, IL-6- and IgG-levels against S.
aureus virulence factors. Results 195 patients from 17 centers were followed;
each patient had an average of 7 visits. Data were analyzed using descriptive
statistics and generalized linear mixed models. Our main hypothesis was only
supported for patients providing throat specimens indicating that patients
with higher density experienced a steeper lung function decline (p<0.001).
Patients with exacerbations (n = 60), S. aureus small-colony variants (SCVs, n
= 84) and co-infection with Stenotrophomonas maltophilia (n = 44) had worse
lung function (p = 0.0068; p = 0.0011; p = 0.0103). Patients with SCVs were
older (p = 0.0066) and more often treated with trimethoprim/sulfamethoxazole
(p = 0.0078). IL-6 levels positively correlated with decreased lung function
(p<0.001), S. aureus density in sputa (p = 0.0016), SCVs (p = 0.0209),
exacerbations (p = 0.0041) and co-infections with S. maltophilia (p = 0.0195)
or A. fumigatus (p = 0.0496). Conclusions In CF-patients with chronic S.
aureus cultures, independent risk factors for worse lung function are high
bacterial density in throat cultures, exacerbations, elevated IL-6 levels,
presence of S. aureus SCVs and co-infection with S. maltophilia. Trial
Registration ClinicalTrials.gov NCT0066976
New strategy for an old problem: Development of a biological control strategy against wireworms in potatoes
Status quo after one year of COVID-19 pandemic in otolaryngological hospital-based departments and private practices in Germany
PURPOSE: The COVID-19 pandemic has affected healthcare systems worldwide. Data on the impact on otolaryngological clinics and private practices is sparse. This study aimed to present data on healthcare worker (HCW) screening, status of HCW, pre-interventional testing, the use of personal protective equipment (PPE) and the economic impact of the pandemic. METHODS: Otolaryngological private practices and hospital-based departments were surveyed nationwide using an online questionnaire. Participating facilities were recruited via the German Society for Oto-Rhino-Laryngology and the German Association for Otolaryngologists in Bavaria. RESULTS: 365 private practices (2776 employees) and 65 hospitals (2333 employees) were included. Significantly more hospitals (68.7%) than practices (40.5%) performed pre-interventional testing in their outpatients (p < 0.00). Most inpatients were tested in practices and hospitals (100.0% and 95.0%; p = 0.08). HCW screening was performed in 73.7% of practices and in 77.3% of hospitals (p = 0.54). Significantly more HCW infections were reported in private practices (4.7%) than in hospital (3.6%; p = 0.03). The private or home environment was the most frequent source of infection among HCW in hospitals (44%) and practices (63%). The use of PPE increased over the course of the pandemic. The number of procedures and the revenue decreased in 2020. CONCLUSION: The rate of pre-interventional testing among outpatients in otolaryngological practices is low and HCW infections were found to be more frequent in practices than in hospitals. In addition, a high rate of infections in otolaryngological HCW seems to stem from the private or home environment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00405-021-06992-2
Health costs in anthroposophic therapy users: a two-year prospective cohort study
BACKGROUND: Anthroposophic therapies (counselling, special medication, art, eurythmy movement, and rhythmical massage) aim to stimulate long-term self-healing processes, which theoretically could lead to a reduction of healthcare use. In a prospective two-year cohort study, anthroposophic therapies were followed by a reduction of chronic disease symptoms and improvement of quality of life. The purpose of this analysis was to describe health costs in users of anthroposophic therapies. METHODS: 717 consecutive outpatients from 134 medical practices in Germany, starting anthroposophic therapies for chronic diseases, participated in a prospective cohort study. We analysed direct health costs (anthroposophic therapies, physician and dentist consultations, psychotherapy, medication, physiotherapy, ergotherapy, hospital treatment, rehabilitation) and indirect costs (sick leave compensation) in the pre-study year and the first two study years. Costs were calculated from resource utilisation, documented by patient self-reporting. Data were collected from January 1999 to April 2003. RESULTS: Total health costs in the first study year (bootstrap mean 3,297 Euro; 95% confidence interval 95%-CI 3,157 Euro to 3,923 Euro) did not differ significantly from the pre-study year (3,186 Euro; 95%-CI 3,037 Euro to 3,711 Euro), whereas in the second year, costs (2,771 Euro; 95%-CI 2,647 Euro to 3,256 Euro) were significantly reduced by 416 Euro (95%-CI 264 Euro to 960 Euro) compared to the pre-study year. In each period hospitalisation and sick-leave together amounted to more than half of the total health costs. Anthroposophic therapies and medication amounted to 3%, 15%, and 8% of total health costs in the pre-study year, first year, and second study year, respectively. The cost reduction in the second year was largely accounted for by a decrease of inpatient hospitalisation, leading to a hospital cost reduction of 519 Euro (95%-CI 377 Euro to 904 Euro) compared to the pre-study year. CONCLUSION: In patients starting anthroposophic therapies for chronic disease, total health costs did not increase in the first year, and were reduced in the second year. This reduction was largely explained by a decrease of inpatient hospitalisation. Within the limits of a pre-post design, study findings suggest that anthroposophic therapies are not associated with a relevant increase in total health costs
Eurythmy therapy in chronic disease: a four-year prospective cohort study
<p>Abstract</p> <p>Background</p> <p>Many patients with chronic diseases use complementary therapies, often provided by their physicians. In Germany, several physician-provided complementary therapies have been reimbursed by health insurance companies as part of health benefit programs. In most of these therapies, the patient has a predominantly passive role. In eurythmy therapy, however, patients actively exercise specific movements with the hands, the feet or the whole body. The purpose of this study was to describe clinical outcomes in patients practising eurythmy therapy exercises for chronic diseases.</p> <p>Methods</p> <p>In conjunction with a health benefit program, 419 outpatients from 94 medical practices in Germany, referred to 118 eurythmy therapists, participated in a prospective cohort study. Main outcomes were disease severity (Disease and Symptom Scores, physicians' and patients' assessment on numerical rating scales 0–10) and quality of life (adults: SF-36, children aged 8–16: KINDL, children 1–7: KITA). Disease Score was documented after 0, 6 and 12 months, other outcomes after 0, 3, 6, 12, 18, 24, and (SF-36 and Symptom Score) 48 months.</p> <p>Results</p> <p>Most common indications were mental disorders (31.7% of patients; primarily depression, fatigue, and childhood emotional disorder) and musculoskeletal diseases (23.4%). Median disease duration at baseline was 3.0 years (interquartile range 1.0–8.5). Median number of eurythmy therapy sessions was 12 (interquartile range 10–19), median therapy duration was 119 days (84–188).</p> <p>All outcomes improved significantly between baseline and all subsequent follow-ups (exceptions: KITA Psychosoma in first three months and KINDL). Improvements from baseline to 12 months were: Disease Score from mean (standard deviation) 6.65 (1.81) to 3.19 (2.27) (p < 0.001), Symptom Score from 5.95 (1.75) to 3.49 (2.12) (p < 0.001), SF-36 Physical Component Summary from 43.13 (10.25) to 47.10 (9.78) (p < 0.001), SF-36 Mental Component Summary from 38.31 (11.67) to 45.01 (11.76) (p < 0.001), KITA Psychosoma from 69.53 (15.45) to 77.21 (13.60) (p = 0.001), and KITA Daily Life from 59.23 (21.78) to 68.14 (18.52) (p = 0.001). All these improvements were maintained until the last follow-up. Improvements were similar in patients not using diagnosis-related adjunctive therapies within the first six study months.</p> <p>Adverse reactions to eurythmy therapy occurred in 3.1% (13/419) of patients. No patient stopped eurythmy therapy due to adverse reactions.</p> <p>Conclusion</p> <p>Patients practising eurythmy therapy exercises had long-term improvement of chronic disease symptoms and quality of life. Although the pre-post design of the present study does not allow for conclusions about comparative effectiveness, study findings suggest that eurythmy therapy can be useful for patients motivated for this therapy.</p
- …